International Online Medical Council (IOMC)

Citations Report

Journal of Diabetes & Metabolism : Citations & Metrics Report

Articles published in Journal of Diabetes & Metabolism have been cited by esteemed scholars and scientists all around the world. Journal of Diabetes & Metabolism has got h-index 43, which means every article in Journal of Diabetes & Metabolism has got 43 average citations.

Following are the list of articles that have cited the articles published in Journal of Diabetes & Metabolism.

	2024	2023	2022	2021	2020	2019
Total published articles	123	107	59	61	45	23
Research, Review articles and Editorials	44	54	37	40	21	22
Research communications, Review communications, Editorial communications, Case reports and Commentary	5	1	2	5	3	0
Conference proceedings	6	16	5	7	0	45
Citations received as per Google Scholar, other indexing platforms and portals	632	946	1156	1199	1039	1106

Journal total citations count	10648
Journal impact factor	12.50
Journal 5 years impact factor	18.23
Journal cite score	23.62
Journal h-index	43

Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescore_y = Citations_y + Citations_y-1 + Citations_y-2 + Citations _y-3 / Published articles_y + Published articles_y-1 + Published articles_y-2 + Published articles _y-3

Important Citations

Bande US, Renukappa VB. CORRELATION BETWEEN HDL-CHOLESTEROL LEVEL AND ANGIOGRAPHIC SEVERITY OF CORONARY ARTERY DISEASE AND IT’S COMPARISON IN PATIENTS WITH AND WITHOUT TYPE 2 DIABETES MELLITUS. Age.;1:0-37. View at Publisher View at Google Scholar
Fruchart JC, Davignon J, Hermans M. Register now to R3i!. Focus. 2019 Dec. View at Publisher View at Google Scholar
Cho KH. High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 1. Impacts of Lifestyle, Diseases, and Environmental Stressors on HDL. Springer; 2019 May 27. View at Publisher View at Google Scholar
Subrahmanyam V. A short literature review on diabetic cardiomyopathy in obese conditions. Journal of Obesity & Weight Loss Therapy. 2014;4(4). View at Publisher View at Google Scholar
Cho KH. High-Density Lipoproteins as Biomarkers and Therapeutic Tools. View at Publisher View at Google Scholar
Cho KH. Change of HDL by Food Ingredient. InHigh-Density Lipoproteins as Biomarkers and Therapeutic Tools 2019 (pp. 287-383). Springer, Singapore. View at Publisher View at Google Scholar
Fruchart JC, Davignon J, Hermans M. R3i EDITORIAL. View at Publisher View at Google Scholar
VONGTHOUNG MK. The Effect of Benjakul Water Extract on Pancreas in Rats Fed a High-fat Diet (Doctoral dissertation, THAMMASAT UNIVERSITY). View at Publisher View at Google Scholar
Kumar V, Ganju L, Garg I. Role of Cyclooxygenase Pathway and Risk Associated with Non-Steroidal Anti-inflammatory Drugs Therapy in Cardiovascular Diseases. Defence Life Science Journal. 2018 Jun 25;3(3):270-6. View at Publisher View at Google Scholar
Fruchart JC, Davignon J, Hermans M, Rosenson RS, FRUCHART JC, AMARENCO P, Sacks F, Ferrieres J, Núñez-Cortés JM, Zambon PA, Fioretto P. Time to prioritise atherogenic dyslipidaemia to reduce residual microvascular risk?. View at Publisher View at Google Scholar
Bande US, Renukappa VB. KEYWORDS ST Elevation MI; Type 2 Diabetes Mellitus; HDL-Cholesterol. CORRELATION BETWEEN HDL-CHOLESTEROL LEVEL AND ANGIOGRAPHIC SEVERITY OF CORONARY ARTERY DISEASE AND IT’S COMPARISON IN PATIENTS WITH AND WITHOUT TYPE 2 DIABETES MELLITUS. 2018 Sep 25(97837). View at Publisher View at Google Scholar
Ribeiro AM, de Araújo S. Prevalencia del síndrome metabólico en una población activa portuguesa del noroeste portugués. View at Publisher View at Google Scholar
Mini GK, Sarma PS, Thankappan KR. Overweight, the major determinant of metabolic syndrome among industrial workers in Kerala, India: Results of a cross-sectional study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019 Sep 1;13(5):3025-30. View at Publisher View at Google Scholar
El-Sayyad HI. Myocardial Oxidative Stress and Metabolic Diseases. InModulation of Oxidative Stress in Heart Disease 2019 (pp. 81-105). Springer, Singapore. View at Publisher View at Google Scholar
Soumya D, Srilatha B. Late stage complications of diabetes and insulin resistance. J Diabetes Metab. 2011 Dec 25;2(9):1000167. View at Publisher View at Google Scholar
Chuguransky SR, Cortizo AM, McCarthy AD. Alendronate can improve bone alterations in experimental diabetes by preventing antiosteogenic, antichondrogenic, and proadipocytic effects of AGEs on bone marrow progenitor cells. BioMed research international. 2016;2016. View at Publisher View at Google Scholar
Gangoiti MV, Arnol V, Cortizo AM, McCarthy AD. Advanced glycation endproducts and alendronate differentially inhibit early and late osteoclastogenesis in vitro. Diabetes & Metabolism. 2013;4. View at Publisher View at Google Scholar
Eknithiset R, Somrongthong R. Effectiveness of a diabetes mellitus pictorial diary handbook program for middle-aged and elderly type 2 diabetes mellitus patients: a quasi-experimental study at Taladnoi Primary Care Unit, Saraburi, Thailand. Journal of multidisciplinary healthcare. 2017;10:327. View at Publisher View at Google Scholar
Li H, Gatsonis C. Combining biomarker trajectories to improve diagnostic accuracy in prospective cohort studies with verification bias. Statistics in medicine. 2019 May 20;38(11):1968-90. View at Publisher View at Google Scholar
Sridevi P, Lakshmi GA, Vunutha K, Akshitha K, Mahesh K, BhagavanRaju M. Dipeptide synthesis and evaluation of antidiabetic activity of 4-hydroxyisoleucine from fenugreek seeds. Pharmaceutical Bioprocessing. 2017 Dec 13;5(4):44-53. View at Publisher View at Google Scholar
Prev 1 2 ... 32 33 34 35 36 37 38 39 40 41 42 ... 136 137 Next »

Journal of Diabetes & Metabolism

Citations Report

Journal of Diabetes & Metabolism : Citations & Metrics Report

Important Citations

Bande US, Renukappa VB. CORRELATION BETWEEN HDL-CHOLESTEROL LEVEL AND ANGIOGRAPHIC SEVERITY OF CORONARY ARTERY DISEASE AND IT’S COMPARISON IN PATIENTS WITH AND WITHOUT TYPE 2 DIABETES MELLITUS. Age.;1:0-37.

Fruchart JC, Davignon J, Hermans M. Register now to R3i!. Focus. 2019 Dec.

Cho KH. High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 1. Impacts of Lifestyle, Diseases, and Environmental Stressors on HDL. Springer; 2019 May 27.

Subrahmanyam V. A short literature review on diabetic cardiomyopathy in obese conditions. Journal of Obesity & Weight Loss Therapy. 2014;4(4).

Cho KH. High-Density Lipoproteins as Biomarkers and Therapeutic Tools.

Cho KH. Change of HDL by Food Ingredient. InHigh-Density Lipoproteins as Biomarkers and Therapeutic Tools 2019 (pp. 287-383). Springer, Singapore.

Fruchart JC, Davignon J, Hermans M. R3i EDITORIAL.

VONGTHOUNG MK. The Effect of Benjakul Water Extract on Pancreas in Rats Fed a High-fat Diet (Doctoral dissertation, THAMMASAT UNIVERSITY).

Kumar V, Ganju L, Garg I. Role of Cyclooxygenase Pathway and Risk Associated with Non-Steroidal Anti-inflammatory Drugs Therapy in Cardiovascular Diseases. Defence Life Science Journal. 2018 Jun 25;3(3):270-6.

Fruchart JC, Davignon J, Hermans M, Rosenson RS, FRUCHART JC, AMARENCO P, Sacks F, Ferrieres J, Núñez-Cortés JM, Zambon PA, Fioretto P. Time to prioritise atherogenic dyslipidaemia to reduce residual microvascular risk?.

Bande US, Renukappa VB. KEYWORDS ST Elevation MI; Type 2 Diabetes Mellitus; HDL-Cholesterol. CORRELATION BETWEEN HDL-CHOLESTEROL LEVEL AND ANGIOGRAPHIC SEVERITY OF CORONARY ARTERY DISEASE AND IT’S COMPARISON IN PATIENTS WITH AND WITHOUT TYPE 2 DIABETES MELLITUS. 2018 Sep 25(97837).

Ribeiro AM, de Araújo S. Prevalencia del síndrome metabólico en una población activa portuguesa del noroeste portugués.

Mini GK, Sarma PS, Thankappan KR. Overweight, the major determinant of metabolic syndrome among industrial workers in Kerala, India: Results of a cross-sectional study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019 Sep 1;13(5):3025-30.

El-Sayyad HI. Myocardial Oxidative Stress and Metabolic Diseases. InModulation of Oxidative Stress in Heart Disease 2019 (pp. 81-105). Springer, Singapore.

Soumya D, Srilatha B. Late stage complications of diabetes and insulin resistance. J Diabetes Metab. 2011 Dec 25;2(9):1000167.

Chuguransky SR, Cortizo AM, McCarthy AD. Alendronate can improve bone alterations in experimental diabetes by preventing antiosteogenic, antichondrogenic, and proadipocytic effects of AGEs on bone marrow progenitor cells. BioMed research international. 2016;2016.

Gangoiti MV, Arnol V, Cortizo AM, McCarthy AD. Advanced glycation endproducts and alendronate differentially inhibit early and late osteoclastogenesis in vitro. Diabetes & Metabolism. 2013;4.

Eknithiset R, Somrongthong R. Effectiveness of a diabetes mellitus pictorial diary handbook program for middle-aged and elderly type 2 diabetes mellitus patients: a quasi-experimental study at Taladnoi Primary Care Unit, Saraburi, Thailand. Journal of multidisciplinary healthcare. 2017;10:327.

Li H, Gatsonis C. Combining biomarker trajectories to improve diagnostic accuracy in prospective cohort studies with verification bias. Statistics in medicine. 2019 May 20;38(11):1968-90.

Sridevi P, Lakshmi GA, Vunutha K, Akshitha K, Mahesh K, BhagavanRaju M. Dipeptide synthesis and evaluation of antidiabetic activity of 4-hydroxyisoleucine from fenugreek seeds. Pharmaceutical Bioprocessing. 2017 Dec 13;5(4):44-53.

Journal Highlights

Journal Flyer

+44 330-822-4832